Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.
Department of Ophthalmology, University of Medicine Grigore T Popa, Iaşi, Romania.
D
D
Călugăru
Department of Ophthalmology, University of Medicine, Cluj-Napoca, Romania.
M
M
Călugăru
D003930:Diabetic Retinopathy; D006801:Humans; D008269:Macular Edema; D040262:Receptors, Vascular Endothelial Growth Factor; D011993:Recombinant Fusion Proteins
D011993:Recombinant Fusion Proteins; D040262:Receptors, Vascular Endothelial Growth Factor